Alnylam Pharmaceuticals, Inc.

Report date
12/31/2025
Quarter
2025 Q4
Filed
2/13/2026
Shares
64,905
Value ($000)
25,810
Weight
0.1%
2022 Q3 - 2025 Q4 (13 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).